Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
The United States is the only wealthy nation in which a large proportion of people lack health insurance coverage. We should all be able to get and afford the health care we need, when we need it. We track U.S. progress toward that goal nationally and by state.
Our nation’s legacy of racism is embedded in our health care system. For many people of color, this legacy has meant less access to quality care and poorer health outcomes. We research and promote the policies and practices needed to achieve an antiracist health system that helps people of color to thrive.